Earnings call transcript: AeroVironment tops Q4 2026 estimates, shares jump 19%

AeroVironment posted a strong Q4 FY2026 beat, with revenue of $641.6 million vs. $557.37 million expected and non-GAAP EPS of $1.84 vs. $1.48, while adjusted EBITDA more than doubled to $140 million. The company raised FY2027 guidance to $2.125 billion-$2.225 billion in revenue and $305 million-$325 million in adjusted EBITDA, but flagged heavy CapEx and negative free cash flow. Shares jumped 19.32% after hours as investors reacted to record sales, margin expansion, and a robust defense demand pipeline.

Analysis

AVAV’s print is less about one quarter and more about proof that the post-BlueHalo mix shift is converting into real operating leverage. The market is starting to price AVAV like a scaled defense platform, not a niche drone supplier, but the hidden second-order effect is that capacity expansion itself becomes a near-term earnings overhang while simultaneously widening the moat: smaller peers can talk growth, but few can fund multi-site production, supplier ecosystem expansion, and product qualification in parallel.

The key positioning takeaway is that the next 2-3 quarters are likely to be governed more by budget timing than by demand. If the funding lag persists, revenue can look choppy even as bookings and backlog remain strong; that creates a setup where the stock can still de-rate on any quarter with acceptance-test slippage or backlog conversion delays despite the bigger multi-year thesis. The real catalyst stack is tied to discrete awards in counter-UAS and kinetic intercept, which could force consensus estimates higher again before FY27 midyear.

The contrarian issue is that the after-hours move may be front-running a smoother path than is likely. The company is explicitly telling you free cash flow goes negative because CapEx is rising faster than near-term monetization, and the market may be underestimating how much margin is exposed to the cadence of government awards and customer acceptance. That said, if the reconciliation budget lands earlier than expected, AVAV has operating leverage to surprise again because incremental volume should carry above-average gross profit, especially in loitering munitions and counter-UAS.

Net: the stock is no longer a simple "beat-and-raise" momentum trade; it is a multi-year capacity build with timing risk in the near term and asymmetric upside if procurement accelerates.

Key Decisions for Investors

• Long AVAV on pullbacks over the next 2-4 weeks; use a staged entry rather than chasing the after-hours gap. Risk/reward is favorable if you are underwriting FY27 as a timing issue, but size modestly because near-term cash burn and budget delays can create 10-15% drawdowns on benign news.
• Buy AVAV Jan-2027 calls or call spreads to express the thesis that capacity build + budget re-acceleration converts into higher FY27/FY28 numbers. Prefer spreads to reduce premium bleed because the stock can stay range-bound until procurement timing clears.
• Pair trade: long AVAV / short a weaker defense tech or small-cap unmanned peer with less manufacturing scale and backlog visibility. The relative winner should be the company that can actually convert demand into supply; AVAV has that edge now, while peers with only narrative and no factory footprint are exposed.
• Take profits on a portion of the post-earnings move if AVAV approaches the prior valuation ceiling before investor day. The market will likely need a concrete catalyst, not just optimism, to keep rerating into a negative free-cash-flow year.
• Set a tactical trigger to add if budget headlines improve or another material award lands in counter-UAS/kinetic intercept. Those are the events most likely to force upward estimate revisions and justify a higher multiple within 1-3 months.